EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject_exact:"Pharmaceutical industry"
Narrow search

Narrow search

Year of publication
Subject
All
Pharmaceutical industry 7,896 Pharmaindustrie 7,651 Arzneimittel 2,957 Pharmaceuticals 2,931 Arzneimittelmarkt 1,360 Pharmaceutical market 1,285 Innovation 1,003 USA 916 United States 879 India 765 Pharmakologie 761 Pharmacology 756 Indien 745 Pharmazeutische Industrie 735 Welt 668 World 668 Deutschland 626 Patent 621 Germany 586 Theorie 572 Theory 572 Industrieforschung 516 Industrial research 508 Innovationsmanagement 421 Innovation management 402 pharmaceutical industry 377 Gesundheitswesen 375 Biotechnology industry 365 Biotechnologie-Industrie 361 Generic drugs 353 Health care system 350 Generika 348 Regulierung 342 Lieferkette 341 Supply chain 341 Regulation 339 Multinationales Unternehmen 337 Intellectual property rights 334 Patentrecht 334 Patent law 332
more ... less ...
Online availability
All
Free 2,477 Undetermined 1,880 CC license 138 Digitizable 4
Type of publication
All
Article 4,351 Book / Working Paper 4,167 Journal 79 Other 6
Type of publication (narrower categories)
All
Article in journal 3,043 Aufsatz in Zeitschrift 3,043 Graue Literatur 1,027 Non-commercial literature 1,027 Aufsatz im Buch 765 Book section 765 Working Paper 704 Arbeitspapier 690 Hochschulschrift 354 Thesis 278 Case study 212 Fallstudie 212 Collection of articles of several authors 163 Sammelwerk 163 Aufsatzsammlung 93 Bibliografie enthalten 64 Bibliography included 64 Konferenzschrift 57 Dissertation u.a. Prüfungsschriften 56 research-article 52 Amtsdruckschrift 51 Government document 51 Conference proceedings 34 Article 32 Business report 31 Geschäftsbericht 31 No longer published / No longer aquired 28 Market information 25 Marktinformation 25 Conference paper 21 Konferenzbeitrag 21 case-report 20 Collection of articles written by one author 19 Sammlung 19 Statistik 16 Festschrift 15 Lehrbuch 15 Statistics 13 review-article 13 Bibliografie 12
more ... less ...
Language
All
English 7,046 German 950 Undetermined 367 French 102 Spanish 49 Italian 39 Russian 20 Portuguese 13 Hungarian 6 Polish 5 Swedish 5 Dutch 4 Croatian 3 Arabic 1 Danish 1 Finnish 1 Japanese 1 Kazakh 1 Norwegian 1 Romanian 1 Slovenian 1 Turkish 1 Ukrainian 1
more ... less ...
Author
All
Berndt, Ernst R. 45 Lichtenberg, Frank R. 44 Higgins, Matthew J. 36 Riccaboni, Massimo 35 Pammolli, Fabio 34 Danzon, Patricia Munch 29 Grabowski, Henry G. 27 Rudholm, Niklas 27 Cockburn, Iain 26 Orsenigo, Luigi 26 Vernon, John A. 24 Henderson, Rebecca 22 Scherer, Frederic M. 22 Granlund, David 21 Chatterjee, Chirantan 20 Dubois, Pierre 20 Lakdawalla, Darius 20 Sampat, Bhaven N. 20 Azoulay, Pierre 19 Seldeslachts, Jo 19 Mehralian, Gholamhossein 18 Scott Morton, Fiona 18 Ceccagnoli, Marco 17 Golec, Joseph 17 Nicholson, Sean 17 Philipson, Tomas J. 17 Phlippen, Sandra 17 Brekke, Kurt R. 16 Harms, Fred 16 Kyle, Margaret K. 16 McGuire, Thomas G. 16 Newham, Melissa 16 Comanor, William S. 15 Li, Danielle 15 Siebert, Ralph 15 Chaudhuri, Sudip 14 Kale, Dinar 14 Malerba, Franco 14 Ornaghi, Carmine 14 Straume, Odd Rune 14
more ... less ...
Institution
All
National Bureau of Economic Research 122 OECD 27 eSocialSciences 14 European Commission / Directorate-General for Health and Food Safety 11 Volkswirtschaftliche Fakultät, Ludwig-Maximilians-Universität München 11 United Nations University-Maastricht Economic Research Institute of Innovation and Technology (UNU-MERIT) 10 Bundesverband der Pharmazeutischen Industrie 9 Springer Fachmedien Wiesbaden 9 Edward Elgar Publishing 8 Europäische Kommission 8 Verband Forschender Arzneimittelhersteller 8 Interpharma 7 Université Paris-Dauphine (Paris IX) 7 World Bank 7 Department of Economics and Business, Universitat Pompeu Fabra 6 United Nations University, Maastricht Economic and social Research and training centre on Innovation and Technology 6 World Trade Organization 6 Großbritannien / Office of Health Economics 5 UNCTAD / Secretariat 5 UNIDO 5 American Enterprise Institute for Public Policy Research 4 Economists Advisory Group 4 European Commission / Directorate-General for Migration and Home Affairs 4 European Monitoring Centre for Drugs and Drug Addiction 4 European Parliament / Directorate-General for Internal Policies of the Union 4 F. Hoffmann-La Roche AG 4 Fraunhofer-Institut für Systemtechnik und Innovationsforschung 4 Institutionen för Nationalekonomi, Umeå Universitet 4 Medizinisch-Pharmazeutische Studiengesellschaft 4 Novartis AG 4 Organisation for Economic Co-operation and Development 4 UNCTAD 4 United Nations Conference on Trade and Development 4 Association of the British Pharmaceutical Industry 3 Centre for Health Economics, Department of Economics and Related Studies 3 Centre for Innovation, Research and Competence in the Learning Economy (CIRCLE), Lunds Universitet 3 Department of Economics and Finance, College of Business and Economics 3 Economics Group, Business School 3 Economics, Markets, Institutions, IMT Lucca Institute for Advanced Studies 3 Esomar 3
more ... less ...
Published in...
All
NBER working paper series 122 NBER Working Paper 89 Working paper / National Bureau of Economic Research, Inc. 77 International journal of pharmaceutical and healthcare marketing : IJPHM 70 Journal of medical marketing : device, diagnostic and pharmaceutical marketing 67 Research policy : policy, management and economic studies of science, technology and innovation 58 Journal of health economics 55 SpringerLink / Bücher 52 The European journal of health economics : HEPAC ; health economics in prevention and care 46 Technology analysis & strategic management 39 International journal of the economics of business 35 Health economics 34 International journal of technology management : IJTM 32 Management science : journal of the Institute for Operations Research and the Management Sciences 30 Industrial and corporate change 28 Research paper 28 Europäische Hochschulschriften / 5 27 PharmacoEconomics 27 Health marketing quarterly 26 International journal of pharmaceutical and healthcare marketing 26 Strategic management journal 25 Technological forecasting & social change : an international journal 25 Managerial and decision economics : MDE ; the international journal of research and progress in management economics 24 Pharmaceutical markets and insurance worldwide 23 Journal of business ethics : JOBE 22 Pharmamarketing : gesundheitsökonomische Aspekte einer innovativen Industrie am Beispiel von Deutschland, Österreich und der Schweiz 21 International journal of production economics 20 International journal of production research 20 R & D management 19 Discussion papers / CEPR 18 International journal of industrial organization 18 Journal of business research : JBR 18 Working paper 18 Applied economics 17 European journal of operational research : EJOR 17 Gabler Edition Wissenschaft 16 Technovation : the international journal of technological innovation, entrepreneurship and technology management 15 Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies 14 Organization science : a journal of the Institute for Operations Research and the Management Sciences ; bridging disciplines to advance knowledge of organizations 14 Working Papers / eSocialSciences 14
more ... less ...
Source
All
ECONIS (ZBW) 7,838 RePEc 354 USB Cologne (EcoSocSci) 219 Other ZBW resources 108 EconStor 54 BASE 25 ArchiDok 5
more ... less ...
Showing 1 - 50 of 8,603
Cover Image
Operations management in the pharmaceutical industry
Anand, Gopesh; Ball, George P.; Gray, John V.; … - In: Journal of operations management 71 (2025) 3, pp. 302-313
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376789
Saved in:
Cover Image
Supply base attributes and diversion risk in a supply chain for hazardous pharmaceutical products
Skilton, Paul F.; Mackelprang, Alan; Sepehrirad, Ramin; … - In: Journal of operations management 71 (2025) 3, pp. 373-392
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376815
Saved in:
Cover Image
Efficiency and super-efficiency in the CRO industry, 2012-2021 : a two-stage exploration
Díaz, Ricardo F.; Sánchez-Robles Rute, Blanca - In: Managerial and decision economics : MDE ; the … 46 (2025) 2, pp. 810-831
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376857
Saved in:
Cover Image
Development of an intelligent model for management of the requirements of marketing projects of the pharmaceutical industry
Rudenko, Elena; Andriienko, Volodymyr - In: Technology audit and production reserves 5 (2024) 2/79, pp. 39-43
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015534367
Saved in:
Cover Image
Competition and pharmaceutical innovation : the moderating role of size and age of leading companies in the market
Jung, Ye Lim; Yoo, Hyoung Sun - In: IEEE transactions on engineering management : EM ; a … 71 (2024), pp. 3088-3097
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015405937
Saved in:
Cover Image
MSD : continuous pharmaceutical manufacturing data for the 2024 MSOM Data-Driven Research Challenge
Martagan, Tugce; Baaijens, Marc; Dirckx, Coen; Holman, James - In: Manufacturing & service operations management : M & SOM 26 (2024) 5, pp. 1587-1604
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015130716
Saved in:
Cover Image
Strategic imperatives for digitisation of the Ukrainian pharmaceutical industry
Safonov, Yuriy; Korotun, Olha; Khmurova, Viktoriia - In: Baltic Journal of Economic Studies 10 (2024) 2, pp. 238-251
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015152961
Saved in:
Cover Image
Dusting off the old ones : drug licensing to startups, innovation success and efficiency
Hammoudeh, Mosab; Krieger, Joshua L.; Xu, Jiajie - 2024
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014529873
Saved in:
Cover Image
Sustaining the integration of social objectives over time : a case-based analysis of access to medicine in the pharmaceutical industry
Bünder, Tobias; Rathert, Nikolas; Mair, Johanna - In: Business & society 63 (2024) 5, pp. 1110-1148
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014577841
Saved in:
Cover Image
Supply chain disruptions during COVID-19 pandemic : key lessons from the pharmaceutical industry
Takawira, Blessing; Pooe, Raborale I. D. - In: South African journal of business management 55 (2024) 1, pp. 1-10
Purpose: This study extends previous research by exploring the key lessons learned by the pharmaceutical industry in South Africa from the COVID-19 pandemic supply chain disruptions. Design/methodology/approach: Having embraced the interpretivist paradigm, 25 supply chain professionals were...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015196528
Saved in:
Cover Image
Data governance in small and medium pharmaceutical enterprises : a dose for a healthier business : Fraunhofer IRB perspectives
Lewis, Katherine; Mattick, Anh; Wuchner, Andrea - 2024
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015604526
Saved in:
Cover Image
The role of Information Technology and employee engagement in enhancing Knowledge Management in the pharmaceutical Research and Development process : insights from dynamic capabilities theory
Chatzifoti, Natalia; Didaskalou, Eleni A.; Chountalas, … - In: Businesses 4 (2024) 3, pp. 315-330
This study investigates the impact of Information Technology and employee engagement on the implementation of Knowledge Management within the Research and Development processes of pharmaceutical companies. Based on Dynamic Capabilities Theory, this research examines the interaction between these...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015098513
Saved in:
Cover Image
An analysis of implementing pharmaceutical cost-containment measures in Egypt : lessons from international experiences
Nassar, Heba; Reda, Dalia - In: Review of economics and political science : REPS 11 (2026) 1, pp. 41-59
Purpose - The main goal of this paper is to analyze the implementation of pharmaceuticals cost-containment measures in Egypt. Design/methodology/approach - This paper adopts descriptive and analytical techniques to assess the extent of implementing pharmaceutical cost-containment measures in...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015560586
Saved in:
Cover Image
Preventing drug shortages through improved demand fulfillment : the untapped potential of postponement and flexibility
Blossey, Gregor; Hahn, Gerd J.; Koberstein, Achim - In: International journal of production economics 293 (2026), pp. 1-12
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015605913
Saved in:
Cover Image
Artificial intelligence adoption for pharmaceutical salesforce performance : a case study in Kuwait
Abdallah, Wael; Aziza, Mulham; Chamas, Hassan Baz - In: Journal of business and socio-economic development 6 (2026) 1, pp. 54-69
Purpose - The research aims to investigate the factors influencing the adoption of artificial intelligence (AI) in pharmaceutical industry companies, specifically focusing on its impact on salesforce performance. Design/methodology/approach - We collected research data from pharmaceutical...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015592497
Saved in:
Cover Image
Should we own a plantation? : German pharmaceutical companies, resource security, and cinchona production in the Dutch East Indies, 1870-1913
Oestermann, Tristan - In: Security strategies in international business history : …, (pp. 21-38). 2026
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015620724
Saved in:
Cover Image
Cognitive supply chain management and risk management in pharmaceuticals : the mediating roles of forecasting, synchronization, and transparency
Abushaikha, Ismail; AlQahtani, Munirah; Bwaliez, Omar M.; … - In: Logistics 10 (2026) 1, pp. 1-21
Background: This study examines the degree to which cognitive supply chain management (CSCM) indirectly enhances supply chain risk management (SCRM), addressing the lack of specific empirical research concerning the underlying mechanisms of this relationship. Specifically, this study tests the...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015611796
Saved in:
Cover Image
Timely access to new pharmaceuticals in Canada, the United States, and the European Union, 2026
Acri, Kristina M. L.; Assad, Lauren - Fraser Institute - 2026
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015613516
Saved in:
Cover Image
Decoding drug search under public funding : rates, directions, and social impacts in an agent-based model
Dosi, Giovanni; Palagi, Elisa; Roventini, Andrea; … - 2026
By extending the framework presented by Dosi et al. (2023b), we build an evolutionary agent-based model of the pharmaceutical sector featuring a government and a Public Research Lab investing in R&D and innovating across different therapeutic areas. After having empirically validated our...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015614624
Saved in:
Cover Image
Risk management of market entry early Korean-German business cooperation in the pharmaceutical industry, 1957-1972
Eichert, Thomas - In: Security strategies in international business history : …, (pp. 139-158). 2026
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015620761
Saved in:
Cover Image
Barriers to Industry 4.0 adoption in pharmaceutical manufacturing companies : a case study
Strüssmann, Breno; Hvam, Lars; Haug, Anders - In: Journal of industrial engineering and management : JIEM 19 (2026) 1, pp. 183-214
Purpose: This study explores the barriers to adopting Industry 4.0 technologies within the pharmaceutical manufacturing sector. Despite the potential for transformative benefits, the sector has been slow in embracing these technologies due to unique regulatory and operational challenges. This...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015627292
Saved in:
Cover Image
Blockchain-based smart contracts for secure record management in the pharmaceutical industry
Aziz, Asfia; Suman, Sunil; Sohail, Shahab Saquib; … - In: International journal of procurement management 25 (2026) 4, pp. 548-573
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015628569
Saved in:
Cover Image
The impact of firm-based organizational citizenship behavior on continuance and normative commitment among pharmaceutical executives : an SEM approach
Oamen, Theophilus Ehidiamen - In: Journal of economics & management 45 (2023) 1, pp. 47-67
Aim/purpose - The study was based on social exchange theory and addressed the effects of firm-based organizational citizenship behavior (OCB) on normative and continuance organizational commitment (OC). Multigroup behavioral differences among pharmaceutical executives were also evaluated....
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014325196
Saved in:
Cover Image
Analysis of trends in the development of the pharmaceutical market of Ukraine in 2007-2021
Mashchenko, Olga; Serhieieva, Lyudmila; Shyshka, Іhor - In: Baltic Journal of Economic Studies 9 (2023) 3, pp. 145-150
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015141689
Saved in:
Cover Image
Covid-19 and the South African pharmaceutical supply chain : drivers, strategies, and recommendations
Takawira, Blessing; Pooe, David Rabolane Isaac - In: International Journal of Research in Business and … 12 (2023) 8, pp. 12-23
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014452622
Saved in:
Cover Image
A strategic response to COVID-19 induced supply chain disruption in South Africa's pharmaceutical industry
Takawira, Blessing; Mutambara, Emmanuel - In: International Journal of Research in Business and … 12 (2023) 8, pp. 61-73
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014452636
Saved in:
Cover Image
Does uncertainty boost exports? : a study on the effect of innovation and marketing capabilities in a small and innovation-intensive sector
Vieira, Jorge; Frade, Rui; Martinho, Filipa; Martinho, … - In: Economies : open access journal 11 (2023) 1, pp. 1-20
The main goal of this research is to study the impact of uncertainty on export performance, from a resource-based perspective. Despite the ample research on how economies behave during periods of high uncertainty, there is still a poor understanding of how this affects smaller sectors,...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013500906
Saved in:
Cover Image
Application de l'exception Bolar: Différentes approches dans le droit de l'UE
Doubinsky, Dmytro - 2025
This Research Paper addresses the growing problem of access to essential medicines, focusing on the role of intellectual property rights, particularly patent rights, in restricting access by enabling pharmaceutical market monopolies that keep drug prices high. The paper explores the Bolar...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015407554
Saved in:
Cover Image
Women Leaders in the Strategic Positions of Pharmaceutical Companies: Overcoming Barriers and Systemic Biases
Nyeleti Mayimele, Nsovo - In: Business Ethics and Leadership 9 (2025) 1, pp. 65-78
The United Nations Sustainable Development Goal (SDG) 5 aims to achieve gender equality and empower all women and girls, emphasising the importance of ensuring full and effective participation and equal opportunities for leadership at all levels of decision-making in political, economic and...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015420576
Saved in:
Cover Image
Pharmaceutical regulation and incentives for innovation in an international perspective
Dubois, Pierre - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015466930
Saved in:
Cover Image
Disclosure and the pace of drug development
Cunnningham, Colleen; Ederer, Florian; Hodgson, Charles; … - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015467032
Saved in:
Cover Image
The impact of technical efficiency on productivity growth : evidence from the Korean pharmaceutical industry
Yun, Mikyung - In: The economic record 101 (2025), pp. 26-49
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015475401
Saved in:
Cover Image
The long-run impact of changes in prescription drug sales on mortality and hospital utilization in Belgium : 1998-2019
Lichtenberg, Frank R. - In: Econometrics : open access journal 13 (2025) 3, pp. 1-31
Objectives: We investigate the long-run impact of changes in prescription drug sales on mortality and hospital utilization in Belgium during the first two decades of the 21st century. Methods: We analyze the correlation across diseases between changes in the drugs used to treat the disease and...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015475567
Saved in:
Cover Image
Free entry and social inefficiency in regulated pharmacy markets
Jokelainen, Antto; Markkanen, Jaakko; Leppälä, Samuli; … - 2025 - [Updated] April 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015486104
Saved in:
Cover Image
Illumina/Grail: the "New Normal" of killer acquisitions and below-threshold acquisitions in search of a reconsideration
Bagnoli, Vicente; Faraone, Nicola M. F - In: Market and competition law review 9 (2025) 2, pp. 105-148
The Illumina/Grail case, which significantly rejected the EU Commission's wide interpretation of its powers of accepting a referral of a merger that did not meet the national merger control thresholds of the referring Member State, introduced changes in the EU about concentrations (Article 22 of...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015554088
Saved in:
Cover Image
Bitter pill for Brussels? : Trump's fight with Irish pharma
Fairbairn, Oskar; Fiedler, Lena; Görg, Holger; Hanley, … - 2025
• Around 60% of Irish net exports to US are pharma products. • A 200% US tariff would devastate all EU exports, not just Ireland's. • Irish business leaders we interviewed are confident that pharma's competitiveness will ensure its survival
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015460683
Saved in:
Cover Image
Competition matters : uniform vs. indication-based pricing of pharmaceuticals
Brekke, Kurt R.; Dalen, Dag Morten; Straume, Odd Rune - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015463573
Saved in:
Cover Image
Research on the relationship between R&D investment, corporate governance and corporate performance : an empirical analysis based on listed pharmaceutical manufacturing enterprises
Wan, Dongqi; Yang, Yao; Kong, Yuanfei - In: International review of economics & finance : IREF 102 (2025), pp. 1-12
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015466488
Saved in:
Cover Image
Assessing consumers' valuation for Front-of-Package "health" labeling under FDA guidelines
Liu, Jianhui; Kassas, Bachir; Lai, John; Fang, Di; … - In: Food policy 131 (2025), pp. 1-14
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015559479
Saved in:
Cover Image
Leveraging knowledge graphs in pharmaceutical supply chains : insights into key drivers of drug shortages
Eberhardt, Katharina; Schwärzel, Amelie; Kaiser, … - In: International journal of production research 63 (2025) 19, pp. 7129-7152
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015547235
Saved in:
Cover Image
Investigating demand forecasting practices and challenges in Ghana's manufacturing pharmaceutical (MPharma) small and medium enterprises (SMEs) : insights and recommendations
Aidoo-Anderson, Albert; Polychronakis, Yiannis; … - In: International journal of production research 63 (2025) 21, pp. 7899-7920
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015549049
Saved in:
Cover Image
The International Finance Corporation's Investments in the Pharmaceutical and Life Sciences Sector
World Bank - 2025
This clustered Project Performance Assessment Report (PPAR) chapeau report synthesizes evaluation findings from six International Finance Corporation (IFC) investment projects in the pharmaceutical and life sciences sector, specifically targeting generic prescription drugs and consumer health...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015454303
Saved in:
Cover Image
Recycling behavior in take-back programs : exploring driving factors and nudge-based interventions for end-user engagement : evidence From Novo Nordisk's take-back program Returpen™
Harden, Cecilie Wagner - 2025 - First edition
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015455331
Saved in:
Cover Image
Effects of debt financing decisions on profitability : a comparison of USA and Europe biopharmaceutical industry
Nkansah, Emmanuel - In: International Journal of Financial Studies : open … 13 (2025) 3, pp. 1-23
Debt financing is important for financing major investments in the biopharmaceutical industry. Debt financing allows companies to raise funds without giving up ownership or control through indenture and covenants of the company. In this study, I analyze the effects of debt financing decisions on...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015457531
Saved in:
Cover Image
Pharmacoeconomics and policy
[Amsterdam] : Elsevier B.V. - Volume 1, issue 1 (2025)-
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015457952
Saved in:
Cover Image
Home remedies : flexibilities to onshore pharmaceutical manufacturing under WTO rules
Mitchell, Andrew D. - In: Journal of international economic law 28 (2025) 1, pp. 23-42
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015425609
Saved in:
Cover Image
Going through the roof : on prices for drugs sold through insurance
Kamphorst, Jurjen; Karamychev, Vladimir A. - In: Games and economic behavior 151 (2025), pp. 218-242
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015426723
Saved in:
Cover Image
Are M&As spurring or stifling innovation? : evidence from antidiabetic drug development
Malek, Jan; Seldeslachts, Jo; Veugelers, Reinhilde - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015435938
Saved in:
Cover Image
Firm-level innovation and the role of political capabilities : evidence for the pharmaceuticals industry
Saha, Amrita; Pozo Segura, Juan Manuel del; Palazzo, Gabriel - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015405762
Saved in:
Cover Image
Deciphering the risk-return dynamics of pharmaceutical companies using the GARCH-M model
Kaur, Arvinder; Chavali, Kavita - In: Risks : open access journal 13 (2025) 5, pp. 1-24
This study focuses on the precise forecasting of stock price movement to determine returns, diversify risk, and demystify existing opportunities. It also aims to gauge the difference in terms of the stock volatility of various pharma companies before and during the pandemic era. The prediction...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015409027
Saved in:
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
  • Last
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...